0.00

100.00% -18.20

Reneo Pharmaceuticals Inc (RPHM)

Overview News Price History Option Chain Financials Why RPHM Down? Discussions Forecast

Reneo Pharmaceuticals Inc stock is traded at $0.00, with a volume of 0. It is down -100.00% in the last 24 hours and down -100.00% over the past month. Reneo Pharmaceuticals Inc is a clinical-stage pharmaceutical company. It is focused on the development of therapies for patients with rare genetic mitochondrial diseases, which are often associated with the inability of mitochondria to produce adenosine triphosphate (ATP). The company is developing REN001 to modulate genes critical to metabolism and generation of ATP, which is the primary source of energy for cellular processes.

Previous Close:

$18.20

Open:

24h Volume:

Relative Volume:

0.00

Market Cap:

$6.08M

Revenue:

Net Income/Loss:

$-77.39M

P/E Ratio:

0.00

EPS:

-2.34

Net Cash Flow:

$-63.90M

1W Performance:

-100.00%

1M Performance:

-100.00%

6M Performance:

-100.00%

1Y Performance:

-100.00%

1-Day Range:

$0.00

1-Week Range:

$0.00

52-Week Range:

$0.00

$78.70

Reneo Pharmaceuticals Inc Stock (RPHM) Company Profile

Name

Reneo Pharmaceuticals Inc

Sector

Healthcare (1181)

Industry

Biotechnology (680)

Phone

(858) 283-0280

Address

18575 JAMBOREE ROAD, IRVINE

Employee

Twitter

Next Earnings Date

2024-11-11

Latest SEC Filings

RPHM's Discussions on Twitter

Reneo Pharmaceuticals Inc Stock (RPHM) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Aug-28-23	Initiated	H.C. Wainwright	Buy
Jul-03-23	Initiated	BofA Securities	Buy
Sep-19-22	Resumed	H.C. Wainwright	Buy
Jan-27-22	Initiated	Robert W. Baird	Outperform
Dec-21-21	Initiated	H.C. Wainwright	Buy
Nov-22-21	Initiated	Ladenburg Thalmann	Buy
May-04-21	Initiated	Jefferies	Buy
May-04-21	Initiated	Piper Sandler	Overweight
May-04-21	Initiated	SVB Leerink	Outperform

View All

Reneo Pharmaceuticals Inc Stock (RPHM) Latest News

Oct 31, 2024

Reneo Pharmaceuticals (NASDAQ:RPHM) Stock Price Up 5.2% – Here’s What Happened - Defense World

Oct 31, 2024

Oct 28, 2024

Octagon Capital Advisors LP Adjusts Stake in Reneo Pharmaceutica - GuruFocus.com

Oct 28, 2024

Oct 23, 2024

Deep Track Capital, LP's Strategic Acquisition in Reneo Pharmace - GuruFocus.com

Oct 23, 2024

Oct 19, 2024

Analysts Offer Predictions for OKUR Q1 Earnings - Defense World

Oct 19, 2024

Oct 18, 2024

What is HC Wainwright's Estimate for OKUR Q1 Earnings? - MarketBeat

Oct 18, 2024

Oct 17, 2024

OnKure Therapeutics (NASDAQ:OKUR) Earns Buy Rating from HC Wainwright - MarketBeat

Oct 17, 2024

Oct 14, 2024

OnKure Therapeutics (OKUR) Stock Rebounds In Extended Session - Stocks Telegraph

Oct 14, 2024

Oct 11, 2024

Cormorant Asset Management's Strategic Acquisition of Reneo Pharmaceuticals Shares - Yahoo Finance

Oct 11, 2024

Deep Track Capital's Strategic Investment in Reneo Pharmaceuticals - Yahoo Finance

Oct 11, 2024

Deep Track Capital's Strategic Investment in Reneo Pharmaceutica - GuruFocus.com

Oct 11, 2024

OnKure shares initiated with Outperform rating on drug potential - Investing.com India

Oct 11, 2024

Perceptive Advisors LLC Acquires New Stake in Reneo Pharmaceuticals Inc - Yahoo Finance

Oct 11, 2024

Oct 10, 2024

Carlyle Group Inc. Reduces Stake in Reneo Pharmaceuticals Inc. - GuruFocus.com

Oct 10, 2024

Recently Listed Cancer Firm OnKure’s Innovative Approach to Breast Cancer Treatment Sparks Analyst Enthusiasm - EMEA Tribune, Breaking News, World News, Latest News, Top Headlines

Oct 10, 2024

OnKure shares initiated with Outperform rating on drug potential By Investing.com - Investing.com Canada

Oct 10, 2024

Oct 08, 2024

Reneo Pharmaceuticals Completes Merger and Name Change to OnKure Therapeutics, Inc. - MarketBeat

Oct 08, 2024

Reneo Pharmaceuticals: Navigating Financial Challenges and Corporate Changes - TipRanks

Oct 08, 2024

Newley merged OnKure raises $65 million - The Pharma Letter

Oct 08, 2024

Oct 07, 2024

Boulder’s OnKure goes public with merger; key drug trial underway - Boulder Daily Camera

Oct 07, 2024

OnKure and Reneo Pharmaceuticals complete merger - Yahoo Finance

Oct 07, 2024

Oct 05, 2024

Reneo Pharmaceuticals stockholders approval merger with OnKure - TipRanks

Oct 05, 2024

Oct 04, 2024

OnKure Announces Closing of Merger with Reneo Pharmaceuticals and Concurrent Private Placement of $65 Million - ForexTV.com

Oct 04, 2024

Reneo stockholders approve merger with OnKure - MSN

Oct 04, 2024

Oct 03, 2024

Reneo Pharmaceuticals secures stockholder approval for OnKure merger By Investing.com - Investing.com Australia

Oct 03, 2024

Reneo Pharmaceuticals Announces Stockholder Approval of Merger with OnKure - StockTitan

Oct 03, 2024

Reneo Pharmaceuticals' Shareholders Approve Merger With OnKure; Reverse Stock Split Imminent - Marketscreener.com

Oct 03, 2024

Oct 02, 2024

Reneo Pharmaceuticals secures stockholder approval for OnKure merger - Investing.com India

Oct 02, 2024

Reneo Pharmaceuticals Announces Stockholder Approval of Merger with OnKure - Benzinga

Oct 02, 2024

Point72 Asia Singapore Pte. Ltd. Takes Position in Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM) - Defense World

Oct 02, 2024

Oct 01, 2024

Nantahala Capital Management LLC Invests $846,000 in Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM) - Defense World

Oct 01, 2024

Sep 27, 2024